It is well established that compliance of patients with a prescribed treatment is often inadequate. This may be due to a complex interaction of factors, prime among them being lack of knowledge, inability, or disinterest. Eye preparations are no exception.' Several teams have undertaken studies in an attempt both to enumerate the extent of the problem and to understand its origin.
One approach has been to use a special drop bottle with an electronic device to record drop administration. In one study2 such a device showed that 41% of patients missed six or more doses over a 30-day period. A similar study3 found that over half the patients missed 20% of their prescribed doses. Other studies have relied on interview'5 and observation67 and have produced similar results. All these studies were undertaken with patients regularly using eyedrops for glaucoma, one of them6 indicating that 13% of patients observed were unable to place drops in both eyes after several attempts.
Interviewing patients using eyedrops after cataract surgery89 revealed a similar range of problems and non-compliance. Other workers have also demonstrated problems with drop size, reporting a wide variation in drop size from commercial eye drops'0 and variation in the number of drops actually expelled by patients. 7 Collectively these studies have shown that many patients have experienced difficulties in self-administration of eyedrops. Some possible reasons for this have been elucidated and some 'at risk' groups identified." Many of the problems appear to be physical, that is, related to the ability ofthe patient to aim a drop accurately into the conjunctival sac. To help them several devices have been used and reported on. Letocha (2) A sheet with a series of concentric circles was used as a target. With the wrist resting on a block at a height of 4 cm the patients were asked to place a drop on the centre of the target.
(3) The patients were asked to instil a drop of hypromellose into one eye of their choice unaided. They were asked to repeat the process using the Easidrop.
(4) A dynamometer (Vigorimeter) was used to measure the pressure of squeeze exerted by finger and thumb (as on a bottle) and by the full hand.
EVALUATION OF BOTTLE
A test rig was used to measure the force required to expel drops of hypromellose from 5, 10, and 20 ml bottles (Cascelloid Division, BXL Containers Ltd). The force was applied at the midpoint on the bottle side, away from the seam. Further tests, on 10 ml bottles only, were carried out to find the effects of the bottle seam, the position of applying the force on the bottle side, the quantity of liquid in the bottle, and the storage temperature on the force required to expel a drop.
Results and discussion

QUESTIONNAIRE
The patients (average age 62, range 9-92) were being treated for glaucoma (32%), following surgery (25%), dry eye (10%), irritation and injury (10%), conjunctivitis, ulcers, and other conditions. Most knew the nature of their condition (96%) and were satisfied with their understanding of it.
Compliance patterns are shown in Table I Table II . Discussion with patients indicated that lack of confidence was a major factor, particularly fear of prodding the eye. As a result the bottle was often held too far from the eye, making the aim more difficult and encouraging the blink reflex. Older patients experienced physical problems in raising the arm, tilting the head, and in holding and squeezing the bottle. Some patients found breaking the tamper-proof seal on a new bottle difficult.
The possibility of a compliance aid was welcomed by 78% of patients, but none were aware that any aids were available. Surprisingly, 72% said that the interview was the first time that they had been asked whether they had problems, while 69% said that they would not tell a doctor of their problems even if asked. This reluctance on behalf of patients was reflected in the lack of awareness among medical staff of the problems experienced by the patients.
ABILITY TESTS
(1) The weight of eyedrop solution in each vial varied from 0-03 g to 0 07 g (mean 0 39 g). Several patients expelled more than one drop.
(2) Most patients said they thought they had aimed the target well. The results are presented in Table III. (3) Only six patients (20%) instilled a drop unaided first time. This was increased to 26 (87%) with the Easidrop device. This latter figure may be artificially high because all the patients were laid flat or almost flat so that no head-tilting was necessary.
(4) The patients had a wide range of grip strength. The pressure recorded was converted to a force based on the area of the Vigorimeter The real significance of the results becomes obvious when these forces are compared with the force which the patients were able to exert. For most there was no problem, but some (approximately 13% ofour sample) could not expel a drop from the bottle. (The questionnaire sample gave a higher figure of 20%.) In general these patients are those who have arthritic conditions, which also reduces their ability to raise the dropper to their eye. It may be physically impossible for this group to self-administer their drops without some additional aid.
For patients who were marginal in their ability to expel drops a second problem emerged from both the questionnaire and the ability tests. As the force being applied approached the limit of their capability, so the wobble of the hand increased. The questionnaire suggested that a further 8% were affected in this way, while observation of the practical tests suggested a much higher figure (approaching 50%). From these data it appears that 25%-50% of patients using eyedrops may have severe physical difficulty in administering them. This will manifest itself in failure to apply them, administering more than one drop (also reported by Kass,7), or opting out and either not trying or using a second person (30% ofpatients). A shaking hand affected the ability of some patients to aim accurately. The ability tests (Table III) showed that only 30% of patients could place a drop within 1 5 cm of the centre of a target (that figure taken to be the approximate size of the eye), and 47% were within 3 cm. This test was carried out in front of the patients, who could clearly see what they were doing. Corroborative evidence came from the questionnaire, where 49% admitted to missing the eye at least occasionally, and from the observation of patients placing drops in the eye, where only 20% managed it first time.
From this work it appears that we have identified two interrelated problems with the self administration of eyedrops: firstly, the lack of physical acuity, and secondly the inability to aim adequately. At present there is in the UK only one aid to assist with administering eyedropsthe Easidrop (produced by Quoteforce, UK). This screws on to the standard bottle neck until the dropper tip is level with a guide mark and, being shaped like an eyebath with cut-away Apart from the evidence we have produced, demographic trends indicate that the number of patients experiencing difficulty will increase rather than decrease. Difficulty in administering drops increases with age. Projections indicate that the population of 85 years old and above will increase by a third over the next 10 years. Unless many of the patients are able to self-administer eyedrops, very heavy demands will be placed on health service resources. Twelve years ago it was estimated that there were 100 000 cases of chronic open-angle glaucoma.4 This figure will have increased, and it takes no account of other conditions requiring the use ofeyedrops. Because of this we have taken steps to develop an aid which will assist with the problems identifiednamely, aim, tilting the head, squeezing the bottle, seeing the drop approaching the eye. It will also help in breaking the tamper-proof seal. A prototype device (Fig 1) is currently undergoing evaluation with patients in both community and hospital. If any compliance aid is to be beneficial, the patient must be aware of its existence. In our questionnaire we found a very disturbing reluctance on the part of patients to Figure I The Opticare compliance aid, developed as a result ofthis study in an attempt to ease the problems experienced in the selfadministration ofeyedrops. The device is currently undergoing evaluation with patients.
tell the doctor about any problems they had. Probably as a consequence of this we also found medical staff were less aware of their patients' problems than is desirable. No doubt the barrier to free communication can be broken down if doctors take a lead. There is probably also a need for an 'awareness campaign' aimed at patients, so that they do not feel guilty or inadequate because they have problems administering their eyedrops. The availability of a suitable device will also help patients achieve safe administration and improve compliance.
